{"name": "iScience Interventional",
 "permalink": "iscience-interventional",
 "crunchbase_url": "http://www.crunchbase.com/company/iscience-interventional",
 "homepage_url": "http://www.iscienceinterventional.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1999,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@iscienceinterventional.com",
 "phone_number": "650.421.2700",
 "description": "Glaucoma treatment devices",
 "created_at": "Wed Jun 24 19:51:00 UTC 2009",
 "updated_at": "Thu Apr 04 06:46:50 UTC 2013",
 "overview": "\u003Cp\u003EiScience Interventional\u00e2\u201e\u00a2 discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies.\u003C/p\u003E\n\n\u003Cp\u003EThis new category of therapy is called Interventional Ophthalmology. It encompasses microcatheter-based therapies designed to access a wide range of anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       88],
      "assets/images/resized/0005/0597/50597v1-max-150x150.jpg"],
     [[150,
       88],
      "assets/images/resized/0005/0597/50597v1-max-250x250.jpg"],
     [[150,
       88],
      "assets/images/resized/0005/0597/50597v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$24.1M",
 "funding_rounds":
  [{"round_code": "f",
    "source_url": "http://onbiovc.com/iscience-interventional-inc-series-f-205m/",
    "source_description": "iScience Interventional, Inc.: Series F $20.5M",
    "raised_amount": 20500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 5,
    "funded_day": 5,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Affinity Capital Management",
         "permalink": "affinity-capital-management",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0004/9410/49410v1-max-150x150.jpg"],
             [[250,
               69],
              "assets/images/resized/0004/9410/49410v1-max-250x250.jpg"],
             [[290,
               81],
              "assets/images/resized/0004/9410/49410v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Johnson \u0026 Johnson Development",
         "permalink": "johnson-johnson-development",
         "image":
          {"available_sizes":
            [[[150,
               61],
              "assets/images/resized/0003/2806/32806v1-max-150x150.png"],
             [[206,
               85],
              "assets/images/resized/0003/2806/32806v1-max-250x250.png"],
             [[206,
               85],
              "assets/images/resized/0003/2806/32806v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "L Capital Partners",
         "permalink": "l-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0002/9187/29187v1-max-150x150.png"],
             [[250,
               68],
              "assets/images/resized/0002/9187/29187v1-max-250x250.png"],
             [[265,
               73],
              "assets/images/resized/0002/9187/29187v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Prism Venture Management",
         "permalink": "prism-venture-management",
         "image":
          {"available_sizes":
            [[[150,
               37],
              "assets/images/resized/0002/7418/27418v1-max-150x150.png"],
             [[250,
               62],
              "assets/images/resized/0002/7418/27418v1-max-250x250.png"],
             [[256,
               64],
              "assets/images/resized/0002/7418/27418v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Three Arch Partners",
         "permalink": "three-arch-partners",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0003/0743/30743v1-max-150x150.png"],
             [[230,
               80],
              "assets/images/resized/0003/0743/30743v1-max-250x250.png"],
             [[230,
               80],
              "assets/images/resized/0003/0743/30743v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "De Novo Ventures",
         "permalink": "de-novo-ventures",
         "image":
          {"available_sizes":
            [[[140,
               77],
              "assets/images/resized/0004/5371/45371v1-max-150x150.jpg"],
             [[140,
               77],
              "assets/images/resized/0004/5371/45371v1-max-250x250.jpg"],
             [[140,
               77],
              "assets/images/resized/0004/5371/45371v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Asset Management Company",
         "permalink": "asset-management",
         "image":
          {"available_sizes":
            [[[150,
               24],
              "assets/images/resized/0001/9262/19262v1-max-150x150.png"],
             [[250,
               41],
              "assets/images/resized/0001/9262/19262v1-max-250x250.png"],
             [[377,
               62],
              "assets/images/resized/0001/9262/19262v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Clarian Health Ventures",
         "permalink": "clarian-health-ventures",
         "image":
          {"available_sizes":
            [[[150,
               65],
              "assets/images/resized/0005/0598/50598v2-max-150x150.png"],
             [[174,
               76],
              "assets/images/resized/0005/0598/50598v2-max-250x250.png"],
             [[174,
               76],
              "assets/images/resized/0005/0598/50598v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://deals.venturebeat.com/2010/08/11/iscience-raises-3-6m-to-treat-eye-diseases/",
    "source_description": "iScience sees $3.6M to treat eye diseases",
    "raised_amount": 3600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 8,
    "funded_day": 11,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "iScience Interventional",
    "address1": "4055 Campbell Avenue",
    "address2": "",
    "zip_code": "94025",
    "city": "Menlo Park",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.4805104,
    "longitude": -122.1807356}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}